MENU
+Compare
TLRY
Stock ticker: NASDAQ
AS OF
Dec 12 closing price
Price
$12.15
Change
+$3.72 (+44.13%)
Capitalization
1.41B

TLRY Tilray Brands Inc. Forecast, Technical & Fundamental Analysis

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis... Show more

Industry: #Biotechnology
TLRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TLRY with price predictions
Dec 11, 2025

TLRY sees its Stochastic Oscillator recovers from oversold territory

On December 11, 2025, the Stochastic Oscillator for TLRY moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 63 instances where the indicator left the oversold zone. In of the 63 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TLRY's RSI Oscillator exited the oversold zone, of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TLRY just turned positive on December 10, 2025. Looking at past instances where TLRY's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TLRY entered a downward trend on December 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.915) is normal, around the industry mean (19.578). P/E Ratio (0.000) is within average values for comparable stocks, (73.186). TLRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.942). TLRY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (1.370) is also within normal values, averaging (64.206).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
TLRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TLRY is expected to report earnings to fall ∞% to -1 cents per share on January 12

Tilray Brands Inc. TLRY Stock Earnings Reports
Q4'25
Est.
$-0.02
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.83
Q4'24
Missed
by $0.06
The last earnings report on October 09 showed earnings per share of 0 cents, beating the estimate of -3 cents. With 84.20M shares outstanding, the current market capitalization sits at 1.41B.
A.I. Advisor
published General Information

General Information

a holding company, whose subsidiaries engages in research, cultivation, processing and distribution of medical cannabis

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
265 Talbot Street West
Phone
+1 844 845-7291
Employees
1600
Web
https://www.tilray.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXHAX13.780.10
+0.73%
Empower Large Cap Value Inv II
DLRHX25.050.16
+0.64%
Nomura Healthcare Fund Class R
OANLX92.020.21
+0.23%
Oakmark Select Institutional
EGLCX10.260.02
+0.20%
Eagle Energy Infrastructure C
UGPIX28.15-0.43
-1.50%
ProFunds UltraChina Inv

TLRY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+2.06%
SNDL - TLRY
76%
Closely correlated
+4.12%
CRON - TLRY
65%
Loosely correlated
+2.15%
CGC - TLRY
62%
Loosely correlated
-1.74%
OGI - TLRY
61%
Loosely correlated
-1.80%
ACB - TLRY
60%
Loosely correlated
+0.44%
More

Groups containing TLRY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+2.06%
TLRY
(2 stocks)
100%
Closely correlated
+29.44%
Pharmaceuticals: Generic
(213 stocks)
32%
Poorly correlated
+1.09%